DEL (DNA-encoded library) technology is transforming how we screen billions of compounds for new drugs—but is it truly a game-changer? What are its biggest breakthroughs, and where does it fall short? Could this be the future of pharmaceuticals, or are there still hurdles to overcome? Share your insights on the promises and challenges of DEL tech!